In our December issue of Pharmaceutical Executive
FEATURES
Cover Story
AstraZeneca's Ruud Dobber: Science Visionary
Lisa Henderson
Drawing from his research roots and the leadership lessons gained in melding business and culture in geographies across the globe, Ruud Dobber, AstraZeneca's executive VP of its North American business, is busy steering the company's US course as it navigates the complexities of a fast-evolving therapeutic market |
Global Health
Fighting the Good Fight
Julian Upton
The industry often finds its global commitments to fighting infectious disease outbreaks and chronic health crises attacked or dismissed as inadequate. But the realities of market economics, fiduciary duty and murky regulatory systems must be factored into the equation. |
Global Health
Partnerships Hold the Key
Michelle Maskaly
Amid a widening net of global health threats, alliances in research and response may be more crucial than ever. |
Commercialization Strategies
Access and Reimbursement for Adoptive T-Cell Transfer Drugs
Jill Condello, Andrea Favaro, Martin Lachs, Rebecca Walker
Outlining the common data transactions between life sciences companies and the HIPAA-regulated stakeholders they deal with daily—and steps pharma can take to secure and protect its own data. |
From the Editor
First Foray into Digital Adherence
Lisa Henderson
FDA's approval of the first-ever digital medicine, while sparking legitimate concerns around ethics and trust, could signal improvements ahead to the much-chronicled woes in drug adherence and compliance. |
ALSO IN THIS ISSUE
A Year of Transformation for Science and Medicine
Jill Wechsler
In 2017, patients gained access to the first gene therapies and more orphan and breakthrough drugs …Read more
Will Europe Turn a Corner on Personalized Medicine?
Reflector
New action plan urges tighter alignment of public health policy with the development of targeted therapies …Read more
Messages of Hope
Michelle Maskaly
Figuring out the right formula to address global health—for the better …Read more
|
| |
| WEBCASTS |
| The Changing Market for Drugs to Treat Orphan Diseases |
| Through the Patient’s Eyes — Needs, Behaviors and the Science Behind It All |
Unlocking the Patient Voice: How Digital Technology Can Facilitate Effective Patient Data Capture in Real-World Data Programs
|
Regenerative Medicine: Overcoming Obstacles to Reimbursement and Market Access
|
Patient Centricity: Turning Rhetoric into Reality
|
Biologics Manufacturing – Is Your Company Ready?
|
Value-Based Engagement Models: Making Collaborations between Pharma and Health Systems Work
|
